Equillium (EQ) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free EQ Stock Alerts $1.54 0.00 (0.00%) (As of 04:27 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 7:37 PM | markets.businessinsider.comBuy Rating on Equillium as Promising Trials and Financial Stability Signal Upside PotentialMay 14 at 8:00 AM | businesswire.comEquillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host DiseaseMay 9, 2024 | msn.comEQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | businesswire.comEquillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical HighlightsMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Equillium on Strong itolizumab Data and Promising EQ101 Phase 2 ProspectsMay 2, 2024 | finance.yahoo.comWe're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn RateApril 4, 2024 | marketbeat.comQ2 2024 EPS Estimates for Equillium, Inc. Lowered by HC Wainwright (NASDAQ:EQ)Equillium, Inc. (NASDAQ:EQ - Free Report) - Research analysts at HC Wainwright cut their Q2 2024 earnings per share (EPS) estimates for shares of Equillium in a research report issued on Tuesday, April 2nd. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($April 3, 2024 | businesswire.comEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 3, 2024 | markets.businessinsider.comBuy Rating Affirmed for Equillium on Strong Clinical Data and Potential Financial UpsidesApril 2, 2024 | msn.comBiotech Rallies Strongly On Second Consecutive Positive HeadlineApril 2, 2024 | marketbeat.comEquillium (NASDAQ:EQ) Price Target Raised to $5.00 at HC WainwrightHC Wainwright lifted their target price on Equillium from $4.00 to $5.00 and gave the stock a "buy" rating in a report on Tuesday.April 1, 2024 | finance.yahoo.comEquillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus NephritisMarch 28, 2024 | marketbeat.comEquities Analysts Offer Predictions for Equillium, Inc.'s Q3 2024 Earnings (NASDAQ:EQ)Equillium, Inc. (NASDAQ:EQ - Free Report) - Equities researchers at Leerink Partnrs boosted their Q3 2024 earnings per share estimates for Equillium in a research note issued on Monday, March 25th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of $0.58 per shaMarch 27, 2024 | marketwatch.comEquillium Shares Fall After Swing to 4Q LossMarch 25, 2024 | investorplace.comEQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023March 25, 2024 | benzinga.comEquillium: Q4 Earnings InsightsMarch 25, 2024 | businesswire.comEquillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical HighlightsMarch 22, 2024 | businesswire.comEquillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational ConferenceMarch 12, 2024 | msn.comBioXcel Therapeutics GAAP EPS of -$0.76 beats by $0.15, revenue of $0.38M misses by $0.36MMarch 3, 2024 | finance.yahoo.comROOT Sep 2024 7.500 putFebruary 24, 2024 | finance.yahoo.comSMCI Mar 2024 970.000 callFebruary 24, 2024 | finance.yahoo.comSMCI Mar 2024 765.000 callFebruary 24, 2024 | sg.finance.yahoo.comSMCI Mar 2024 800.000 putFebruary 23, 2024 | uk.finance.yahoo.comSMCI Feb 2024 1460.000 putFebruary 23, 2024 | finance.yahoo.comSMCI Mar 2024 695.000 putFebruary 23, 2024 | benzinga.comEquillium Stock (NASDAQ:EQ), Short Interest ReportFebruary 13, 2024 | finance.yahoo.comBiosimilar Interleukins ( IL-17, IL-23, IL-1, IL-5, IL-6 ) Global Market Report 2024 - Robust CAGR of 40% Predicted by 2028November 20, 2023 | finance.yahoo.comEQ Bank Card launches in Québec as Carte Banque EQNovember 15, 2023 | benzinga.comEquillium Stock (NASDAQ:EQ), Analyst Ratings, Price Targets, PredictionsNovember 13, 2023 | finance.yahoo.comEquillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of RheumatologyNovember 8, 2023 | finance.yahoo.comEquillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNovember 6, 2023 | finance.yahoo.comEquillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of NephrologyNovember 2, 2023 | finance.yahoo.comEquillium, Inc. (EQ) Stock Historical Prices & Data - Yahoo FinanceNovember 1, 2023 | msn.comEquillium (EQ) Price Target Increased by 11.23% to 7.24October 21, 2023 | finance.yahoo.comEquillium, Inc. (EQ) Interactive Stock Chart - Yahoo FinanceOctober 19, 2023 | finance.yahoo.comEquillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of RheumatologyOctober 16, 2023 | finance.yahoo.comEquillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics SymposiumOctober 3, 2023 | businesswire.comEquillium to Host Analyst & Investor DayOctober 2, 2023 | finance.yahoo.comEquillium to Present at the JonesTrading 2023 Healthcare SummitSeptember 20, 2023 | finance.yahoo.comEquillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event ConferencesAugust 30, 2023 | finance.yahoo.comEquillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor ConferenceAugust 14, 2023 | msn.comCantor Fitzgerald Reiterates Equillium (EQ) Overweight RecommendationAugust 14, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Their Buy Rating for Equillium (EQ)August 14, 2023 | finance.yahoo.comAnalysts Just Made A Substantial Upgrade To Their Equillium, Inc. (NASDAQ:EQ) ForecastsAugust 12, 2023 | finance.yahoo.comEquillium, Inc. (NASDAQ:EQ) Just Reported, And Analysts Assigned A US$6.06 Price TargetAugust 9, 2023 | msn.comStabilis Energy GAAP EPS of -$0.12, revenue of $12.91M misses by $12.09MAugust 9, 2023 | msn.comEquillium GAAP EPS of -$0.10 beats by $0.06, revenue of $9.12M beats by $2.98MAugust 9, 2023 | msn.comEquillium, Inc. (EQ) Reports Q2 Loss, Tops Revenue EstimatesAugust 9, 2023 | finance.yahoo.comEquillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesAugust 3, 2023 | seekingalpha.comEquillium approves $7.5M share buyback, stock jumps more than 30% after hours Get Equillium News Delivered to You Automatically Sign up to receive the latest news and ratings for EQ and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open. Click now for the best way into the newest AI projects EQ Media Mentions By Week EQ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EQ News Sentiment▼0.760.55▲Average Medical News Sentiment EQ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EQ Articles This Week▼71▲EQ Articles Average Week Get Equillium News Delivered to You Automatically Sign up to receive the latest news and ratings for EQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kronos Bio News Today Aileron Therapeutics News Today Eagle Pharmaceuticals News Today Kezar Life Sciences News Today Carisma Therapeutics News Today Mural Oncology News Today Checkpoint Therapeutics News Today MediciNova News Today AEON Biopharma News Today CalciMedica News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EQ) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBill Clinton Backing Biden Replacement???The Freeport SocietyHow to Play the AI and Crypto Markets in One SwingWeiss RatingsAmazon's betting big on this unknown AI companyManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equillium, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
